Significance of a reduction in HCV RNA levels at 4 and 12 weeks in patients infected with HCV genotype 1b for the prediction of the outcome of combination therapy with peginterferon and ribavirin

Significance of a reduction in HCV RNA levels at 4 and 12 weeks in patients infected with HCV genotype 1b for the prediction of the outcome of combination therapy with peginterferon and ribavirin

<p>Abstract</p> <p>Background</p> <p>The importance of the reduction in hepatitis C virus (HCV) RNA levels 4 and 12 weeks after starting peginterferon (PEG-IFN) and ribavirin combination therapy has been reported to predict a sustained virologic response (SVR) in patien...

Full description

Bibliographic Details
Main Authors: Toyoda Hidenori, Kumada Takashi, Shimada Noritomo, Takaguchi Koichi, Ide Tatsuya, Sata Michio, Ginba Hiroyuki, Matsuyama Kazuhiro, Izumi Namiki
Format: Article
Language:English
Published: BMC 2012-11-01
Series:BMC Infectious Diseases
Subjects:
Chronic hepatitis C
Peginterferon
Ribavirin
Reduction in HCV RNA levels
Four and twelve weeks
Baseline factors
Response-guided therapy
Extended treatment
Online Access:http://www.biomedcentral.com/1471-2334/12/324

Internet

http://www.biomedcentral.com/1471-2334/12/324

Similar Items